Which of the following is NOT true about Metformin?

Metformin is a widely used medication for managing type 2 diabetes and is known for several characteristics. One key fact is that it generally does not cause hypoglycemia when used alone, as its mechanism primarily enhances insulin sensitivity and reduces hepatic glucose production without increasing insulin secretion. This means that it does not lead to the low blood sugar levels associated with other diabetes medications that stimulate insulin release.

The claim that Metformin does not cause weight loss is somewhat misleading; while it may not cause significant weight loss, many patients experience weight stabilization or even modest weight loss, making it more favorable for overweight individuals with type 2 diabetes. The maximum prescribed dose is indeed typically around 2000 to 2550 mg per day, depending on the formulation and individual patient tolerance. Importantly, Metformin is known to have positive effects on lipid profiles, which can be beneficial for patients who are at risk for cardiovascular disease.

In summary, while Metformin can help with weight management and lipid levels, and its maximum dosage is well-documented, it is not associated with an increased risk of hypoglycemia, making the assertion regarding hypoglycemia incorrect.